USFDA completes inspection at FDC’s manufacturing plant

13 Feb 2023 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at FDC’s manufacturing plant located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which manufactures sterile ophthalmic products from February 6, 2023 to February 12, 2023.The said audit has been successfully completed by the USFDA with No observations (Zero 483’s). The audit was carried out for the sterile ophthalmic products being marketed in the US.

FDC made a modest beginning with marketing of vitamins and a range of prescription formulations. The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.

FDC Share Price

420.35 -0.50 (-0.12%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×